IGF-1 is a hormone that signals growth and tissue building, affecting bone tissue, cartilage, posture quality, and muscle density; low IGF-1 causes slow recovery, weak training response, flat/tired appearance, and limited growth adaptation.

The claim that IGF-1 (Insulin-like Growth Factor 1) is a hormone involved in signaling growth and tissue building, affecting bone tissue, cartilage, posture, and muscle density is broadly supported by scientific understanding. IGF-1 plays a critical role in anabolic processes, promoting bone growth and muscle repair. Low IGF-1 levels are associated with impaired recovery and reduced adaptive responses to training, which can manifest as a less robust physical appearance and limited growth adaptation. However, the provided sources are mostly non-trusted and do not directly confirm these details, limiting the strength of evidence. Furthermore, some nuances, such as the complexity of IGF-1 interactions with other hormones and factors influencing posture and cartilage, are not fully addressed. Therefore, while the core biological role of IGF-1 is accurate, the claim’s detailed assertions about posture quality and specific symptoms of low IGF-1 require more robust, trusted evidence for full validation.